BindingDB logo
myBDB logout

6 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
24660890 12 Omarigliptin (MK-3102): a novel long-acting DPP-4 inhibitor for once-weekly treatment of type 2 diabetes.EBI Merck & Co., Inc.
22850208 60 Dipeptidyl peptidase-4 inhibitor withß-amino amide scaffold: synthesis, SAR and biological evaluation.EBI Dong-A Pharm. Co., Ltd
19217790 68 Medicinal chemistry approaches to the inhibition of dipeptidyl peptidase-4 for the treatment of type 2 diabetes.EBI Matrix Laboratories Limited
18201067 276 Discovery of potent and selective dipeptidyl peptidase IV inhibitors derived from beta-aminoamides bearing subsituted triazolopiperazines.EBI Merck Research Laboratories
19539471 130 Aminopiperidine-fused imidazoles as dipeptidyl peptidase-IV inhibitors.EBI Merck& Co. Inc.
17433672 16 Rational design of a novel, potent, and orally bioavailable cyclohexylamine DPP-4 inhibitor by application of molecular modeling and X-ray crystallography of sitagliptin.EBI Merck Research Laboratories